© 2021 MJH Life Sciences and HCPLive - Clinical news for connected physicians. All rights reserved.
© 2021 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
The HCPLive ADHD condition center page is a comprehensive resource for clinical news and insights on ADHD. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for ADHD.
May 01, 2021
The transition from pediatric care to adult care can be confusing for ADHD patients, often leading to a discontinuation of health care services altogether.
The rates of both diseases have been increasingly linked in recent years.
April 13, 2021
Investigators conclude data show diminishing returns in treating mild cases of ADHD, but more research is needed to bridge long-term positives and negatives.
April 09, 2021
The main predictors of SCWT performance was maternal education and housing conditions.
April 02, 2021
The approval comes after Supernus resubmitted an application to address issues outlined in a FDA CRL.
The study represents the first to examine a PPD connection to allopregnanolone.
March 26, 2021
The analysis was less statistically powered when comparing sibling discordant.
March 19, 2021
Optimizing care and managing challenges for patients with ADHD during the COVID-19 pandemic and advice for clinicians educating patients and families on disease management.
Rakesh Jain, MD, MPH, shares his thoughts on whether drug holidays are appropriate for children taking medication for ADHD.
A discussion on the recent development of investigational serotonin norepinephrine modulating agent (SNMA), SPN-812, for the treatment of ADHD in adults.